期刊文献+

腹水miRNA-497、miRNA-936测定在胃癌性腹水腹腔化疗联合全身靶向治疗中的意义 被引量:5

下载PDF
导出
摘要 目的探讨腹水中miRNA-497、miRNA-936水平对于胃癌性腹水患者疗效评估及预后判断的价值。方法检测治疗组(给予腹腔化疗联合全身靶向治疗)21例和对照组(仅给予腹腔化疗)30例患者腹水中miRNA-497、miRNA-936水平。结果治疗组和对照组腹水中miRNA-497、miRNA-936水平治疗后较治疗前均明显下降(P<0.05);治疗组治疗后腹水中miRNA-497、miRNA-936水平低于对照组(P<0.05)。治疗组有效率为38.10%,对照组有效率16.67%(P<0.05)。结论胃癌性腹水腹腔化疗联合全身靶向治疗具有极其重要的潜在治疗价值,miRNA-497、miRNA-936在胃癌性腹水临床治疗中具有重要的疗效评估及预后判断的价值。
作者 项涛 雷慧
出处 《肿瘤基础与临床》 2013年第2期142-144,共3页 journal of basic and clinical oncology
  • 相关文献

参考文献13

  • 1Volinia S, Calin GA, Liu CG, et al. A micmRNA expression signa- ture of human solid tumors defines cancer gene targets [ J ]. Proc Natl Acad Sci U S A,2006,103 (7) :2257 - 2261.
  • 2Li X, Zhang Y, Zhang Y, et al. Survival prediction of gastric cancer by a seven-microRNA signature[ J]. Gut,2010,59(5 ) :579 - 585.
  • 3Ueda T, Volinia S, Okumura H, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a mi- croRNA expression analysis [ J ]. Lancet Oncol, 2010,11 ( 2 ) : 136 - 146.
  • 4Tie J,Pan Y,Zhao L, et al. MiR-218 inhibits invasion and metasta- sis of gastric cancer by targeting the Robol receptor[ J]. PLoS Gen- et ,2010,6 (3) : e1000879.
  • 5Cho WJ, Shin JM, Kim JS, et al. miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regu- lation of LATS2 [ J]. Mol Cells ,2009,28 (6) :521 - 527.
  • 6Zhu W,Shan X,Wang T,et al. miR-181b modulates multidrug re- sistance by targeting BCL2 in human cancer cell lines [ J ]. Int J Cancer,2010,127 ( 11 ) :2520 - 2529.
  • 7Rossi L, Bonmassar E, Faraoni I. Modification of miR gene expres- sion pattern in human colon cancer cells following exposure to 5- fluorouracil in vitro [ J ]. Pharmacol Res ,2007,56 ( 3 ) :248 - 253.
  • 8Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapop- totic factor in human glioblastoma cells [ J ]. Cancer Res,2005,65 ( 14 ) :6029 - 6033.
  • 9Tsukamoto Y, Nakada C, Noguchi T, et al. MicroRNA-375 is down- regulated in gastric carcinomas and regulates cell survival by targe- ting PDK1 and 14-3-3zeta [ J ]. Cancer Res, 2010,70 ( 6 ) : 2339 - 2349.
  • 10Wong TS, Liu XB,Wong BY, et al. Mature miR-184 as potential on- cogenic microRNA of squamous cell carcinoma of tongue [ J ]. Clin Cancer Res,2008,14 (9) :2588 - 2592.

同被引文献57

  • 1Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量:214
  • 2Bartel DP. MicroRNAs: target recognition and regulatory functions [J]. Ce11,2009,136(2) :215 -233.
  • 3Lund E, GOttinger S, Calado A, et al. Nuclear export of microRNA preeursors [ J 1- Science,2004,303 (5654) :95 - 98.
  • 4Lai KW, Koh KX, Loh M, et al. MiemRNA-130b regulates the turnour suppressor RUNX3 in gastric cancer[ J]. Eur J Cancer, 2010,46 ( 8 ) : 1456 - 1463.
  • 5Suresh S,McCallum L,Lu W,et al. MicroRNAs 130a/b are regula- ted by BCR-ABL and downregulate expression of CCN3 in CML [J]. J Cell Commun Signal,2011,5(3) :183 -191.
  • 6Li BL,Lu C,Lu W,et al. miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer[ J]. Med Oneo1,2013,30( 1 ) :484.
  • 7Kang H,Hata A. MieroRNA regulation of smooth muscle gene expres- sion and phenotype[ J]. Curr Opin Hematol,2012,19(3).224-231.
  • 8Davis-Dusenbery BN, Wu C, Hata A. Mieromanaging vascular smooth muscle cell differentiation and phenotypic modulation [ J ]. Arterio- scler Thromb Vase Biol,2011,31 ( 11 ) :2370 -2377.
  • 9Wu WK, Lee CW, Cho CH,et al. MicroRNA dysregulation ingastric cancer: a new player enters the game [J]. Oncogene, 2010,29(43 ) :5761 -5771.
  • 10Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function [J]. Cell, 2004,116(2) :281 -297.

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部